Drug intelligence / Profile preview

meizitanc

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

Meizitanc is a product marketed as a weight loss dietary supplement. It is often sold under names such as "Meizitang Botanical Slimming Soft Gel" and "Meizitang Citrus." Despite being promoted as an all-natural herbal supplement for slimming and weight loss, laboratory analyses by regulatory agencies have repeatedly found that various versions of this product contain undeclared pharmaceutical ingredients. These include sibutramine (an appetite suppressant withdrawn from many markets due to cardiovascular risks), diclofenac (a non-steroidal anti-inflammatory drug), dipyrone (an analgesic banned in several countries due to risk of agranulocytosis), and sildenafil or its metabolites (a prescription-only medication for erectile dysfunction)[1][2][3][5]. The presence of these hidden drugs poses significant health risks including increased blood pressure, heart palpitations, nervousness, headache, tremor, and potentially life-threatening interactions with other medications[1][2][3][5]. The product has not been approved by major regulatory authorities for safety or efficacy.

Brand names
meizitancMeizitang Botanical Slimming Soft GelMeizitang Strong Version Botanical Slimming Soft GelMeizitang Citrus
Other names
meizitancMeizitangMeizi Tang
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)

Beyond the preview

Go deeper on meizitanc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on meizitanc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call